Overview This page contains the latest trade data of Antisera and other blood fractions. In 2022, Antisera and other blood fractions were the world's 435th most traded product, with a total trade of $9.17B. Between 2021 and 2022 the exports of Antisera and other blood fractions decreased by -95.4%, from $200B to $9.17B. Trade in Antisera and other blood fractions represent 0.039% of total world trade.
Antisera and other blood fractions are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2022 the top exporters of Antisera and other blood fractions were Ireland ($2.34B), United States ($1.38B), Germany ($813M), South Korea ($622M), and France ($525M).
Imports In 2022 the top importers of Antisera and other blood fractions were United States ($1.45B), China ($724M), Germany ($660M), Netherlands ($641M), and Chinese Taipei ($438M).
Ranking Antisera and other blood fractions ranks 210th in the Product Complexity Index (PCI).